If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
53.50    -1.50 (-2.73%)
Bid:
53.00
Ask:
54.00
Spread: 1.00 (1.887%)
Market Cap: £102.64m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

IOSorb Patent Awarded

2 Aug 2013 08:30

RNS Number : 8247K
Iofina PLC
02 August 2013
 



2 August 2013

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

 

IOSorb Patent Awarded

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to report that the Company has been awarded a US patent with regards to its IOsorb™ iodine extraction technology.

The new patent was awarded for Iofina's technology, already in use at IO#1 and IO#2, that provides removal of iodine from brine streams that contain hydrocarbon contaminates and are located at the injection site of the operator. These are key components of Iofina's technology as all the Company's sources of iodine are from hydrocarbon contaminated brine streams which are co-produced waste streams associated with shale oil and gas production based at the producer's injection site.

Conventional methods of extracting iodine are typically intolerant of high temperatures and rendered ineffective by hydrocarbon fouling. The conventional iodine extraction systems also are immobile and not modular or mobile like Iofina's WET® IOsorb™ units. This therefore makes conventional iodine extraction systems ill-suited for deployment which is also included in this patent. The issued patent was originally filed in the United States and has been also filed in Chile and Japan shortly thereafter.

Commenting, Chris Fay, Executive Chairman, said: "The IOsorb™ technology is the only technology known which is oil field proven for large scale commercial production of iodine. This patent is a key component in protecting Iofina's IOsorb™ technology utilised in the emerging shale boom in North America.

"We are delighted we have been issued the patent and will continue to finalise the Company's additional patents and trademarks relating to the Company's IOsorb™ technology to ensure a robust intellectual property (IP) portfolio for the Company."

 

 

For further information, please contact:

 

Dr. Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

 

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUUBROOAWRRR
Date   Source Headline
31st Oct 20137:00 amRNSCommissioning of IO#3 iodine extraction plant
9th Oct 20137:00 amRNSOperational Update
2nd Oct 20132:40 pmRNSHolding(s) in Company
26th Sep 20133:32 pmRNSHolding(s) in Company
25th Sep 20137:00 amRNSHalf Yearly Report
19th Sep 20137:00 amRNSDirectorate Change
6th Sep 20137:00 amRNSNotice of Results
16th Aug 20137:00 amRNSBoard Appointment
2nd Aug 20138:30 amRNSIOSorb Patent Awarded
1st Aug 20137:00 amRNSOperational Update
4th Jul 20138:56 amRNSDirector/PDMR Shareholding
3rd Jul 20135:40 pmRNSChange of Registered Office
28th Jun 20132:05 pmRNSDirector/PDMR Shareholding
25th Jun 20138:15 amRNSProduction & Produced Water Congress 2013
24th Jun 20132:22 pmRNSHolding(s) in Company
24th Jun 201312:00 pmRNSResponse to Share Price Movement
19th Jun 20132:10 pmRNSResult of AGM
19th Jun 20137:00 amRNSAGM Statement
17th Jun 20135:01 pmRNSHolding(s) in Company
12th Jun 201310:08 amRNSBoard Changes
5th Jun 20137:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20137:00 amRNSCompletion of US$15m Convertible Bond Issue
8th May 20137:00 amRNSSuccessful Arrangement of US$15m Convertible Bond
7th May 20137:00 amRNSFinal Results
2nd May 20137:00 amRNSChange in Reporting Currency
29th Apr 20137:47 amRNSNotice of Final Results
29th Apr 20137:00 amRNSAtlantis Water Project Update
17th Apr 20137:00 amRNSHolding(s) in Company
15th Apr 20137:00 amRNSBoard Update
3rd Apr 20135:30 pmRNSHolding(s) in Company
28th Mar 20137:55 amRNSAtlantis Water Project
27th Mar 20134:09 pmRNSHolding(s) in Company
11th Mar 20135:19 pmRNSHolding(s) in Company
7th Mar 20137:00 amRNSOperational Update
11th Feb 20131:34 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSHolding(s) in Company
14th Jan 20137:00 amRNSAppointment of Non-Executive Director
11th Jan 20137:00 amRNSCommissioning of IO#2 IOsorbT Plant
20th Dec 20128:12 amRNSHolding(s) in Company
18th Dec 20129:00 amRNSHolding(s) in Company
4th Dec 20127:00 amRNSProduction Update
17th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSNotice of Results
16th Aug 20127:00 amRNSCommissioning of Plant
31st Jul 20127:00 amRNSCompletion of Construction of IO#1 IOsorb Plant
20th Jun 20122:25 pmRNSResult of AGM
20th Jun 20127:00 amRNSPurchase of Iodine Extraction Facility
7th Jun 20127:00 amRNSHolding(s) in Company
25th May 20127:00 amRNSPlacing to raise £4.3 million
25th May 20127:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.